Involvement of both major histocompatibility complex class II α and β chains in CD4 function indicates a role for ordered oligomerization in T cell activation

Journal of Experimental Medicine

Volumn 182, Issue 3, 1995, Pages 779-787

  König, Rolf ^a   Shen, Xiaoli ^a   Germain, Ronald N ^b  

^a UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

^b NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MUTANT PROTEIN; PROTEIN TYROSINE KINASE; T LYMPHOCYTE RECEPTOR;

ANIMAL CELL; ANTIGEN EXPRESSION; ANTIGEN RECOGNITION; ANTIGEN SPECIFICITY; ARTICLE; HUMAN; HUMAN CELL; HYBRIDOMA; MAJOR HISTOCOMPATIBILITY COMPLEX; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN LOCALIZATION; T LYMPHOCYTE ACTIVATION;

ANIMAL; ANTIGENS, CD4; BINDING SITES; DNA, COMPLEMENTARY; GENES, MHC CLASS II; HLA-D ANTIGENS; HUMAN; LYMPHOCYTE ACTIVATION; MICE; MODELS, MOLECULAR; MUTAGENESIS, SITE-DIRECTED; PROTEIN CONFORMATION; STRUCTURE-ACTIVITY RELATIONSHIP; T-LYMPHOCYTES; TRANSFECTION;

EID: 0029150969     PISSN: 00221007     EISSN: 15409538     Source Type: Journal    
DOI: 10.1084/jem.182.3.779     Document Type: Article

References (53)

1. Swain, S.L. 1983. T cell subsets and the recognition of MHC class. Immunol. Rev. 74: 129-142.
2. Biddison, W.E., and S. Shaw. 1989. CD4 expression and function in HLA class II-specific T cells. Immunol Rev. 109: 5-15.
3. Bierer, B.E., B.P. Sleckman, S.E. Ratnofsky, and S.J. Burakoff. 1989. The biologic roles of CD2, CD4, and CD8 in T-cell activation. Amu. Rev. Immunol. 7: 579-599.
4. Doyle, C., and J.L. Strominger. 1987. Interaction between CD4 and class II MHC molecules mediates cell adhesion. Nature (Lond.). 330: 256-259.
5. Clayton, L.K., M. Sieh, D.A. Pious, and E.L. Reinherz. 1989. Identification of human CD4 residues affecting class II MHC versus HIV-1 gpl20 binding. Nature (Lond.). 339: 548-551.
6. Janeway, C.A., J. Rojo, K. Saizawa, U. Dianzani, P. Pbrtoles, J. Tite, S. Haque, and B. Jones. 1989. The co-receptor function of murine CD4. Immunol. Rev. 109: 77-92.
7. Janeway, C.A. 1992. The T cell receptor as a multicomponent signalling machine: CD4/CD8 coreceptors and CD45 in T cell activation. Annu. Rev. Immunol. 10: 645-674.
8. Xu, H., and D.R. Littman. 1993. A kinase-independent function of Lck in potentiating antigen-specific T cell activation. Cell. 74: 633-643.
9. Vignali, D.A.A., and J.L. Strominger. 1994. Coreceptor function and the characteristics of MHC-bound peptides: a common link? The Immunologist. 2: 112-118.
10. Veillette, A., M.A. Bookman, E.M. Horak, and J.B. Bolen. 1988. The CD4 and CD8 T cell surface antigens are associated with the internal membrane tyrosine-protein kinase p56lck. Cell. 55: 301-308.
11. lck with cytoplasmic domains of CD4 and CD8 is mediated by cysteine motifs. Cell. 60: 755-765.
12. von Boehmer, H. 1994. Positive selection of lymphocytes. Cell. 76: 219-228.
13. lck complex in T lymphocytes: a potential mechanism to regulate T-cell growth. Biochem. Cell Biol. 67: 581-589.
14. lck. Nature (Lond.). 338: 257-259.
15. Miceli, M.C., and J.R. Pames. 1993. Role of CD4 and CD8 in T cell activation and differentiation. Adv. Immunol. 53: 59-122.
16. Zamoyska, R. 1994. The CD8 coreceptor revisited: one chain good, two chains better. Immunity. 1: 243-246.
17. Kaufman, J.F., and J.L. Strominger. 1979. Both chains of HLA-DR bind to the membrane with a penultimate hydrophobic region and the heavy chain is phosphorylated at its hydrophobic carboxy terminus. Proc. Natl. Acad. Sci. USA. 76: 6304-6308.
18. Shackelford, D.A., J.F. Kaufman, A.J. Korman, and J.L. Strominger. 1982. HLA-DR antigens: structure, separation of subpopulations, gene cloning and function. Immunol. Rev. 66: 133-187.
19. Brown, J.H., T. Jardetzky, M.A. Saper, B. Samraoui, P.J. Bjorkman, and D.C. Wiley. 1988. A hypothetical model of the foreign antigen binding site of class II histocompatibility molecules. Nature (Lond.). 332: 845-850.
20. Brown, J.H., T.S. Jardetzky, J.C. Gorga, L.J. Stern, R.G. Urban, J.L. Strominger, and W.D. C. 1993. Three-dimensional structure of the human class II histocompatibility antigen HLA-DR1. Nature (Lond.). 364: 33-39.
21. Cammarota, G., A. Scheirle, B. Takacs, D.M. Doran, R. Knorr, W. Bannwarth, J. Guardiola, and F. Sinigaglia. 1992. Identification of a CD4 binding site on the β2 domain of HLA-DR molecules. Nature (Lond.). 356: 799-801.
22. Konig, R., L.Y. Huang, and R.N. Germain. 1992. MHC class II interaction with CD4 mediated by a region analogous to the MHC class I binding site for CD8. Nature (Lond.). 356: 796-798.
23. Marrack, P., R. Endres, R. Shimonkevitz, A. Zlotnik, D. Dialynas, F. Fitch, and J. Kappler. 1983. The major histocompatibility complex-restricted antigen receptor on T cells. II. Role of the L3T4 product. J. Exp Med. 158: 1077-1091.
24. Glaichenhaus, N., N. Shastri, D.R. Littman, and J.M. Turner. 1991. Requirement for association of p56lck with CD4 in antigen-specific signal transduction in T cells. Cell. 64: 511-520.
25. d mouse major histocompatibility antigen genes in L cells after DNA-mediated gene transfer. J. Immunol. 130: 463-470.
26. bm12 mutation using site-directed mutagenesis and DNA-mediated gene transfer. J. Immunol. 139: 629-638.
27. Lemke, H., G.J. Hammerling, and U. Hammerling. 1979. Fine specificity analysis with monoclonal antibodies of antigens controlled by the major histocompatibility complex and by the Qa/TL region in mice. Immunol. Rev. 47: 175-206.
28. Kappler, J.W., B. Skidmore, J. White, and P. Marrack. 1981. Antigen-inducible, H-2-restricted, interleukin-2-producing T cell hybridomas. Lack of independent antigen and H-2 recognition. J. Exp Med. 153: 1198-1214.
29. Bhattacharya, A., M.E. Dorf, and T.A. Springer. 1981. A shared alloantigenic determinant on la antigens encoded by the I-A and I-E subregions: evidence for I region gene duplication. J. Immunol. 127: 2488-2495.
30. Dalbadie-McFarland, G., L.W. Cohen, A.D. Riggs, C. Morin, K. Itakura, and J.H. Richards. 1982. Oligonucleotide-directed mutagenesis as a general and powerful method for studies of protein function. Proc. Natl. Acad. Sci. USA. 79: 6409-6413.
31. Ho, S.N., H.D. Hunt, R.M. Horton, J.K. Pullen, and L.R. Pease. 1989. Site-directed mutagenesis by overlap extension using the polymerase chain reaction. Gene (Amst.). 77: 51-59.
32. Miller, J., and R.N. Germain. 1986. Efficient cell surface expression of class IIMHC molecules in the absence of associated invariant chain. J. Exp. Med. 164: 1478-1489.
33. Kaufman, J.F., C. Auffray, A.J. Korman, D.A. Shakelford, and J. Strominger. 1984. The class II molecules of the human and murine major histocompatibility complex. Cell. 36: 1-13.
34. Travers, P., T.L. Blundell, M.J. Sternberg, and W.F. Bodmer. 1984. Structural and evolutionary analysis of HLA-D-region products. Nature (Lond.). 310: 235-238.
35. Brownstein, N.S., and R.N. Germain. 1987. Allele-specific control of la molecule surface expression and conformation: implications for a general model of la structure-function relationships. Proc. Natl. Acad. Sci. USA. 84: 2921-2925.
36. Gorga, J.C., A. Dong, M.C. Manning, R.W. Woody, W.S. Caughey, and J.L. Strominger. 1989. Comparison of the secondary structures of human class I and class II major histocompatibility complex antigens by Fourier transform infrared and circular dichroism spectroscopy. Proc. Natl. Acad. Sci. USA. 86: 2321-2325.
37. Germain, R.N. 1994. MHC-dependent antigen processing and peptide presentation: providing ligands for T lymphocyte activation. Cell. 76: 287-299.
38. Bjorkman, P.J., M.A. Saper, B. Samraoui, W.S. Bennett, J.L. Strominger, and D.C. Wiley. 1987. Structure of the human class I histocompatibility antigen, HLA-A2. Nature (Lond.). 329: 506-512.
39. Salter, R.D., R.J. Benjamin, P.K. Wesley, S.E. Buxton, T.P.J. Garrett, C. Clayberger, A.M. Krensky, A.M. Norment, D.R. Littman, and P. Parham. 1990. A binding site for the T-cell co-receptor CD8 on the a3 domain of HLA-A2. Nature (Lond). 345: 41-46.
40. Kabat, E.A., T.T. Wu, H.M. Perry, K.S. Gottesman, and C. Foeller. 1991. Sequences of proteins of immunological interest. 5th edition. U.S. Department of Health and Human Services, Public Health Service, National Institutes of Health, Bethesda, MD. 1-1137.
41. Cosgrove, D., H. Bodmer, M. Bogue, C. Benoist, and D. Mathis. 1992. Evaluation of the functional equivalence of major histocompatibility complex class II A and E complexes. J. Exp. Med. 176: 629-634.
42. Weber, S., and K. Karjalainen. 1993. Mouse CD4 binds MHC class II with extremely low affinity. Int. Immunol. 5: 695-698.
43. Wang, J.H., Y.W. Yan, T.P. Garrett, J.H. Liu, D.W. Rodgers, R.L. Garlick, G.E. Tarr, Y. Husain, E.L. Reinherz, and S.C. Harrison. 1990. Atomic structure of a fragment of human CD4 containing two immunoglobulin-like domains. Nature (Lond.). 348: 411-418.
44. Moebius, U., P. Pallai, S.C. Harrison, and E.L. Reinherz. 1993. Delineation of an extended surface contact area on human CD4 involved in class II major histocompatibility complex binding. Proc. Natl. Acad. Sci. USA. 90: 8259-8263.
45. Dintzis, H.M., R.Z. Dintzis, and B. Vogelstein. 1976. Molecular determinants of immunogenicity: the immunon model of immune response. Proc Natl. Acad. Sci. USA. 73: 3671-3675.
46. Ullrich, A., and J. Schlessinger. 1990. Signal transduction by receptors with tyrosine kinase activity. Cell. 61: 203-212.
47. Evavold, B.D., and P.M. Allen. 1991. Separation of IL-4 production from Th cell proliferation by an altered T cell receptor ligand. Science (Wash. DC). 252: 1308-1310.
48. De Magistris, M.T., J. Alexander, M. Coggeshall, A. Altman, F.C. Gaeta, H.M. Grey, and A. Sette. 1992. Antigen analog-major histocompatibility complexes act as antagonists of the T cell receptor. Cell. 68: 625-634.
49. Racioppi, L., F. Ronchese, L.A. Matis, and R.N. Germain. 1993. Peptide-major histocompatibility complex class II complexes with mixed agonist/antagonist properties provide evidence for ligand-related differences in T cell receptor-dependent intracellular signaling. J. Exp Med. 177: 1047-1060.
50. Sloan-Lancaster, J., A.S. Shaw, J.B. Rothbard, and P.M. Allen. 1994. Partial T cell signaling: altered phospho-ζ and lack of ZAP-70 recruitment in APL-induced T cell anergy. Cell. 79: 913-922.
51. Madrenas, J., R.L. Wange, J.L. Wang, N. Isakov, L.E. Samelson, and R.N. Germain. 1995. ζ phosphorylation without ZAP-70 activation induced by TCR antagonists or partial agonists. Science (Wish. DC). 267: 515-518.
52. Jameson, S.C., and M.J. Bevan. 1995. T cell receptor antagonists and partial agonists. Immunity. 2: 1-12.
53. Germain, R.N., E.H. Levine, and J. Madrenas. 1995. The T cell receptor as a diverse signal transduction machine: molecular models and implications for understanding T cell development and function. The Immunologist. 3/4: 97-105.